Canada Pension Plan Investment Board’s Rigel Pharmaceuticals RIGL Stock Holding History

Canada Pension Plan Investment Board’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$735K	Sell	18,800 -6,500	-26%	-$200K	﹤0.01%	1117
2026 Q1	$684K	Buy	25,300 +1,100	+5%	+$37K	﹤0.01%	1123
2025 Q4	$1.04M	Buy	+24,200	New	+$912K	﹤0.01%	1058
2020 Q3	–	Sell	-66,900	Closed	-$1.22M	–	1315
2020 Q2	$1.22M	Buy	+66,900	New	+$1.2M	﹤0.01%	870
2018 Q4	–	Sell	-25,000	Closed	-$803K	–	1332
2018 Q3	$803K	Buy	25,000 +20,000	+400%	+$600K	﹤0.01%	1114
2018 Q2	$142K	Buy	+5,000	New	+$178K	﹤0.01%	1159
2014 Q2	–	Sell	-1,900	Closed	-$74K	–	1286
2014 Q1	$74K	Buy	+1,900	New	+$67.7K	﹤0.01%	1087

Other funds holding RIGL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Canada Pension Plan Investment Board's RIGL Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its Rigel Pharmaceuticals (RIGL) stake by 26% in Q2 2026, selling an estimated $200K and leaving 18,800 shares worth $735K. The position accounts for ﹤0.01% of the portfolio, ranked #1117.

Canada Pension Plan Investment Board first reported a position in RIGL in Q1 2014 and has held it in 7 quarters since. The position peaked at $1.22M in Q2 2020. 155 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

Canada Pension Plan Investment Board held 18,800 shares of Rigel Pharmaceuticals worth $735K as of Q2 2026.
Canada Pension Plan Investment Board sold 6,500 Rigel Pharmaceuticals shares in Q2 2026, an estimated $200K.
Rigel Pharmaceuticals made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1117 holding.
Canada Pension Plan Investment Board first reported a position in Rigel Pharmaceuticals in Q1 2014 and has held it in 7 quarters since.
Canada Pension Plan Investment Board's Rigel Pharmaceuticals position peaked at $1.22M in Q2 2020.
155 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.